Application 078269

Type
ANDA
Sponsor
RISING

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RISPERIDONERISPERIDONETABLET;ORAL0.25MGNoNo
002RISPERIDONERISPERIDONETABLET;ORAL0.5MGNoNo
003RISPERIDONERISPERIDONETABLET;ORAL1MGNoNo
004RISPERIDONERISPERIDONETABLET;ORAL2MGNoNo
005RISPERIDONERISPERIDONETABLET;ORAL3MGNoNo
006RISPERIDONERISPERIDONETABLET;ORAL4MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
13107-119RisperidoneRisperidoneAurolife Pharma LLCANDACurrent
13107-120RisperidoneRisperidoneAurolife Pharma LLCANDACurrent
13107-121RisperidoneRisperidoneAurolife Pharma LLCANDACurrent
13107-122RisperidoneRisperidoneAurolife Pharma LLCANDACurrent
13107-123RisperidoneRisperidoneAurolife Pharma LLCANDACurrent
13107-124RisperidoneRisperidoneAurolife Pharma LLCANDACurrent
57237-226RisperidoneRisperidoneCitron Pharma LLCANDACurrent
57237-227RisperidoneRisperidoneCitron Pharma LLCANDACurrent
57237-228RisperidoneRisperidoneCitron Pharma LLCANDACurrent
57237-229RisperidoneRisperidoneCitron Pharma LLCANDACurrent
57237-230RisperidoneRisperidoneCitron Pharma LLCANDACurrent
57237-231RisperidoneRisperidoneCitron Pharma LLCANDACurrent
65862-119RisperidoneRisperidoneAurobindo Pharma LimitedANDACurrent
65862-120RisperidoneRisperidoneAurobindo Pharma LimitedANDACurrent
65862-121RisperidoneRisperidoneAurobindo Pharma LimitedANDACurrent
65862-122RisperidoneRisperidoneAurobindo Pharma LimitedANDACurrent
65862-123RisperidoneRisperidoneAurobindo Pharma LimitedANDACurrent
65862-124RisperidoneRisperidoneAurobindo Pharma LimitedANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
23900ORIG2008-11-25